Celadon Pharmaceuticals PLC Defensive Interval Ratio
Celadon Pharmaceuticals PLC defensive interval ratio. Celadon Pharmaceuticals PLC (CEL) has a Defensive Interval Ratio of -83 days as of June 2024. Defensive assets of GBX-199.00K (cash GBX-, short-term investments GBX-272.00K, receivables GBX73.00K) cover -83 days of daily cash needs of GBX2.41K/day. See CEL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Celadon Pharmaceuticals PLC (2019–2023)
Defensive interval ratio of Celadon Pharmaceuticals PLC from 2019 to 2023. This chart shows how Celadon Pharmaceuticals PLC's Defensive Interval Ratio has evolved across 5 annual periods from 2019 to 2023. As of June 2024, the ratio stands at -83 days, meaning defensive assets of GBX-199.00K can fund -83 days of operations without new revenue. Check CEL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Celadon Pharmaceuticals PLC Defensive Interval Ratio by Year (2019–2023)
Celadon Pharmaceuticals PLC defensive interval ratio by year from 2019 to 2023. The table below presents the year-by-year Defensive Interval Ratio for Celadon Pharmaceuticals PLC from 2019 to 2023, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of Celadon Pharmaceuticals PLC.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 29 days | GBX75.00K | GBX2.62K/day | GBX- | GBX- | ▼ -295 days |
| 2022 | 324 days | GBX1.06 Million | GBX3.28K/day | GBX- | GBX- | ▼ -4080 days |
| 2021 | 4404 days | GBX2.13 Million | GBX484.74/day | GBX- | GBX- | ▲ +4403 days |
| 2020 | 0 days | GBX599.00 | GBX2.29K/day | GBX- | GBX- | ▼ -1 days |
| 2019 | 2 days | GBX300.00 | GBX183.08/day | GBX- | GBX- | — |